rs1131769
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_198282.4(STING1):c.695A>G(p.His232Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.873 in 1,613,916 control chromosomes in the GnomAD database, including 615,846 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_198282.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STING1 | NM_198282.4 | c.695A>G | p.His232Arg | missense_variant | 6/8 | ENST00000330794.9 | NP_938023.1 | |
STING1 | NM_001301738.2 | c.695A>G | p.His232Arg | missense_variant | 6/7 | NP_001288667.1 | ||
STING1 | NM_001367258.1 | c.338A>G | p.His113Arg | missense_variant | 5/7 | NP_001354187.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STING1 | ENST00000330794.9 | c.695A>G | p.His232Arg | missense_variant | 6/8 | 1 | NM_198282.4 | ENSP00000331288 | P1 |
Frequencies
GnomAD3 genomes AF: 0.871 AC: 132374AN: 151992Hom.: 57673 Cov.: 31
GnomAD3 exomes AF: 0.876 AC: 220195AN: 251454Hom.: 96547 AF XY: 0.875 AC XY: 118967AN XY: 135902
GnomAD4 exome AF: 0.874 AC: 1276983AN: 1461806Hom.: 558127 Cov.: 62 AF XY: 0.874 AC XY: 635860AN XY: 727206
GnomAD4 genome AF: 0.871 AC: 132478AN: 152110Hom.: 57719 Cov.: 31 AF XY: 0.869 AC XY: 64615AN XY: 74332
ClinVar
Submissions by phenotype
STING-associated vasculopathy with onset in infancy Benign:3
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 14, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 99% of patients studied by a panel of primary immunodeficiencies. Number of patients: 95. Only high quality variants are reported. - |
not provided Benign:1Other:1
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | This variant is associated with the following publications: (PMID: 23707065, 24204993, 33154747, 31866997) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at